Waters Corporation (WAT)

Create an Alert
101.89 +1.68  +1.68%   NYSE Jun 18, 5:00PM BATS Real time Currency in USD

Waters Corporation R&D Expense Quarterly:

25.31M for March 31, 2013
View Full Chart

Waters Corporation R&D Expense Quarterly Chart

    Waters Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 25.31M
    Dec. 31, 2012 24.96M
    Sept. 30, 2012 23.76M
    June 30, 2012 23.94M
    March 31, 2012 23.35M
    Dec. 31, 2011 23.71M
    Sept. 30, 2011 23.37M
    June 30, 2011 23.01M
    March 31, 2011 22.25M
    Dec. 31, 2010 22.87M
    Sept. 30, 2010 20.52M
    June 30, 2010 20.81M
    March 31, 2010 20.08M
    Dec. 31, 2009 19.79M
    Sept. 30, 2009 19.31M
    June 30, 2009 19.72M
    March 31, 2009 18.33M
    Dec. 31, 2008 19.63M
    Sept. 30, 2008 19.95M
    June 30, 2008 22.23M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    WAT R&D Expense Quarterly Benchmarks

    Companies
    Agilent Technologies 181.00M
    Thermo Fisher Scientific 98.20M
    Mettler-Toledo International 27.70M

    WAT R&D Expense Quarterly Rankings

    Overall 97th percentile
    489 of 16773
    Sector 91st percentile
    118 of 1408 in Healthcare
    Industry 92nd percentile
    10 of 130 in Diagnostics & Research

    WAT R&D Expense Quarterly Range, Past 5 Years

    Minimum 18.33M Mar 2009
    Maximum 25.31M Mar 2013
    Average 21.84M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');